-
Mashup Score: 0Validation of the BCIS-1 myocardial jeopardy score using cardiac magnetic resonance perfusion imaging - PubMed - 3 year(s) ago
The recently described angiographic BCIS-1 Myocardial Jeopardy Score (BCIS-JS) provides a semi-quantitative estimate of the extent of coronary artery disease (CAD). It is simple to use and applicable to all patients including those with bypass grafts. Our objective was to validate the BCIS-JS by eva …
Source: PubMedCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0
BACKGROUND: Limited evidence exists regarding long-term effectiveness and safety of aldosterone antagonists (AAs) versus beta blockers (BBs) as fourth-line antihypertensive agents in patients with re
Source: HypertensionCategories: Cardiologists, Latest HeadlinesTweet-
Very interesting study re: treatment of resistant hypertensive patients with aldosterone antagonists. Comparative Safety and Effectiveness of Aldosterone Antagonists Versus Beta-Blockers as Fourth Agents in Patients With Apparent Resistant Hypertension https://t.co/hYwhKxWpbk
-
-
Mashup Score: 0The VA cooperative randomized study of surgery for coronary arterial occlusive disease II. Subgroup with significant left main lesions - PubMed - 3 year(s) ago
From a large cooperative prospective randomized study, data relating to a subgroup of 113 patients with angina pectoris and a significant lesion of the left main coronary artery were analyzed. Of these patients, 53 had been randomly allocated to a medical treatment group and 60 to a surgical treatme …
Source: PubMedCategories: Cardiologists, Latest HeadlinesTweet-
@djc795 @mmamas1973 @EulertJ @purviparwani @JGrapsa @Hragy @ShariqShamimMD @DrMarthaGulati @DavidLBrownMD @iamritu @pabeda1 @hvanspall https://t.co/2I3BFcPTlL
-
-
Mashup Score: 6Choosing a Method for Guiding PCI | NEJM - 3 year(s) ago
Editorial from The New England Journal of Medicine — Choosing a Method for Guiding PCI
Source: New England Journal of MedicineCategories: Cardiologists, Latest HeadlinesTweet-
RT @NEJM: New editorial by Jane A. Leopold, M.D.: "Choosing a Method for Guiding PCI" https://t.co/FUgODgyRpe https://t.co/NVtRtQn8Gd
-
-
Mashup Score: 4
URL: http://www.clinicaltrials.gov. Unique identifier: NCT00023595.
Source: PubMedCategories: Cardiologists, Latest HeadlinesTweet-
SIMPLE FACT: Avg age is *TEN YEARS* younger in STICH vs REVIVED. Analysis by @markcpetrie20 shows assoc of age w/outcomes in STICH: https://t.co/SMkwE8WI21 It’s one reason better GDMT still had high mortality in MT arm of REVIVED & why very difficult to compare across trials. https://t.co/rQdjmN4a26
-
-
Mashup Score: 0REVIVE-ing a Weak Heart — Details Matter | NEJM - 3 year(s) ago
Editorial from The New England Journal of Medicine — REVIVE-ing a Weak Heart — Details Matter
Source: New England Journal of MedicineCategories: Cardiologists, Latest HeadlinesTweet-
For some perspective on #REVIVED #ESCCongress REVIVE-ing a Weak Heart — Details Matter | NEJM https://t.co/fpQYXF2Kz8 The control group is KEY here and congrats to the investigators. GDMT is no doubt fantastic but I am very interested to see what was actually treated.
-
-
Mashup Score: 10
OPTIMUM is the first prospective, multicenter study to examine treatment strategies and outcomes among multivessel CAD patients deemed ineligible for surgical revascularization after Heart Team assessment. This registry will provide unique insights into the clinical decision-making, revascularizatio …
Source: PubMedCategories: Cardiologists, Latest HeadlinesTweet-
RT @agtruesdell: 👍Important Registry: very relevant to day-to-day practice for many of us👏: https://t.co/UMDQyNeAto… #OPTIMUM https://t.co/…
-
-
Mashup Score: 4
FootnotesReferences1. Dugan E, Ferraro R, Hamo C, Ambinder D, Goyal A. The CardioNerds #CardsJC: how Twitter journal clubs elevate the scientific discourse.J Card Fail. 2021; 27:1034–1036. doi: 10.1016/j.cardfail.2021.04.012CrossrefMedlineGoogle Scholar2. Das TM, Kaur GM, Nematollahi S, Ambinder D, Shafer K, Sulistio M, Berlacher K, Goyal A. Medical education in the digital era: a new paradigm…
Source: CirculationCategories: Cardiologists, Latest HeadlinesTweet-
This is a really great summary / interview w/@CardioNerds - thanks @MaryjaneFarrMD and @CircAHA Collab, Virtualize, Democratize: A Conversation With the Founders of CardioNerds https://t.co/QjmdouYgSk
-
-
Mashup Score: 0Surgery After TAVR: Waiting a Month or More Not Really Better - 3 year(s) ago
Prosthesis-patient mismatch, paravalvular regurgitation the bigger issues for surgical candidates
Source: www.medpagetoday.comCategories: Cardiologists, Latest HeadlinesTweet-
Surgery After TAVR: Waiting a Month or More Not Really Better https://t.co/VNxcJzkaCA
-
-
Mashup Score: 4Subclinical Leaflet Thrombosis and Anticoagulation After Transcatheter Aortic Valve Replacement - 3 year(s) ago
This narrative review discusses several studies that have investigated the role for oral anticoagulation in patients after transcatheter aortic valve replacement, with a focus on the issue of subclinical leaflet thrombosis.
Source: jamanetwork.comCategories: Cardiologists, Latest HeadlinesTweet-
Congratulations to Tom Cahill (outgoing structural heart fellow @nyphospital for this fantastic review. Tom will be starting soon at Oxford and will do great things! Subclinical Leaflet Thrombosis & Anticoagulation After TAVR https://t.co/2P5j478ogB via @JAMACardio @JAMANetwork
-
4/Nicely written and published full BCIS-JS/CMR validation paper is below; correlation of score w/MRI-based ischemia assessment is a primary conclusion. There are some caveats for the low EF population openly stated (to authors’ credit): https://t.co/045OARiW3l https://t.co/mTY9IhdkSA